CN114133593A - Cellulose-polyethylene glycol-layered silicon dioxide composite hydrogel and application thereof - Google Patents

Cellulose-polyethylene glycol-layered silicon dioxide composite hydrogel and application thereof Download PDF

Info

Publication number
CN114133593A
CN114133593A CN202111405230.2A CN202111405230A CN114133593A CN 114133593 A CN114133593 A CN 114133593A CN 202111405230 A CN202111405230 A CN 202111405230A CN 114133593 A CN114133593 A CN 114133593A
Authority
CN
China
Prior art keywords
cellulose
polyethylene glycol
composite hydrogel
hydrogel
molecular weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202111405230.2A
Other languages
Chinese (zh)
Other versions
CN114133593B (en
Inventor
胡怡晨
潘震
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Ruining Biotechnology Co ltd
Original Assignee
Shanghai Ruining Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Ruining Biotechnology Co ltd filed Critical Shanghai Ruining Biotechnology Co ltd
Priority to CN202111405230.2A priority Critical patent/CN114133593B/en
Publication of CN114133593A publication Critical patent/CN114133593A/en
Application granted granted Critical
Publication of CN114133593B publication Critical patent/CN114133593B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/02Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075Macromolecular gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001Use of materials characterised by their function or physical properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001Use of materials characterised by their function or physical properties
    • A61L24/0031Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/02Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/046Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/025Other specific inorganic materials not covered by A61L27/04 - A61L27/12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/20Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/02Inorganic materials
    • A61L31/028Other inorganic materials not covered by A61L31/022 - A61L31/026
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/042Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/06Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/06Flowable or injectable implant compositions
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2301/00Characterised by the use of cellulose, modified cellulose or cellulose derivatives
    • C08J2301/08Cellulose derivatives
    • C08J2301/26Cellulose ethers
    • C08J2301/28Alkyl ethers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2371/00Characterised by the use of polyethers obtained by reactions forming an ether link in the main chain; Derivatives of such polymers
    • C08J2371/02Polyalkylene oxides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2401/00Characterised by the use of cellulose, modified cellulose or cellulose derivatives
    • C08J2401/08Cellulose derivatives
    • C08J2401/26Cellulose ethers
    • C08J2401/28Alkyl ethers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2471/00Characterised by the use of polyethers obtained by reactions forming an ether link in the main chain; Derivatives of such polymers
    • C08J2471/02Polyalkylene oxides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/34Silicon-containing compounds
    • C08K3/36Silica
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K7/00Use of ingredients characterised by shape

Abstract

The invention discloses a cellulose-polyethylene glycol-layered silicon dioxide composite hydrogel which comprises modified water-soluble cellulose and/or salt thereof, layered silicon dioxide, polyethylene glycol, inorganic salt and water. According to the invention, the stability of the cellulose hydrogel is improved by using the lamellar silicon dioxide, and meanwhile, the polyethylene glycol is added into the system, so that the problem that the viscosity of the system is greatly increased due to the lamellar silicon dioxide is remarkably improved, and the method is suitable for injection or treatment of introducing the cellulose hydrogel through a thin catheter. Compared with a chemical crosslinking method, the composite hydrogel disclosed by the invention has the advantages of no introduction of a crosslinking agent and simplicity in use, and has a wide application prospect.

Description

Cellulose-polyethylene glycol-layered silicon dioxide composite hydrogel and application thereof
Technical Field
The invention belongs to the field of biomedical materials, and particularly relates to injectable cellulose-polyethylene glycol-layered silicon dioxide composite hydrogel and application thereof.
Technical Field
Cellulose is a linear polymer formed by connecting D-glucopyranose units (AGU) by beta-1, 4 glycosidic bonds, is the most abundant organic polymer in the nature, has the properties of regeneration, green and biocompatibility, and is an important basic raw material for chemical engineering. Cellulose molecules have a large number of hydrogen bonds, complex intermolecular and intramolecular hydrogen bond actions are easily formed, and the cellulose is insoluble in water and common organic solvents due to high crystallinity. The current cellulose modification technology mainly comprises two aspects of etherification and esterification. The cellulose ether is a cellulose derivative prepared by etherifying and modifying cellulose, is soluble in water and an organic solvent, has the functions of thickening, film forming and the like in an aqueous solution, has good biocompatibility and biodegradability, is safe and non-toxic, has no irritation to skin and mucous membrane, has no immunoreaction, and is widely applied in the medical field.
However, although the modified cellulose has the advantages of good biocompatibility and biodegradability and has extremely high application value as a biological material, the modified cellulose has the disadvantages of rapid absorption in the human body and short residence time in tissues, so that the application is limited, and the degradation time of the cellulose hydrogel is generally improved in the form of physical crosslinking, chemical crosslinking or a composite material.
Patent US10052408B2 reports that an anti-blocking material based on carboxymethyl cellulose can improve the stability of the system by physically crosslinking carboxymethyl cellulose and polyethylene glycol with calcium ions. Patent CN104327307A discloses a method for preparing cellulose-based biodegradable hydrogel, which uses polyethylene glycol diglycidyl ether as a cross-linking agent to obtain biodegradable carboxymethyl cellulose hydrogel, and the degradation rate of the hydrogel can be adjusted by adjusting the ratio of carboxymethyl cellulose to the cross-linking agent.
In addition, the physical properties of the hydrogel can be regulated by adding inorganic nanomaterials. Silica layered materials have been widely used as active ingredients or viscosity modifiers in pharmaceuticals, cosmetics and foods due to their unique electrostatic properties, uniform size and biological activity. For example, the stability of hydrogel can be improved by adding silica layered material into gelatin, and the degradation rate in 48 hours is improved from 50% to nearly 90%. (Biotechnol. J.2020,1900456) the Laponite silica layered material was added to alginic acid hydrogel to make a shear-thinning non-Newtonian fluid that could be injected through a syringe to form a solid gel in vivo. (adv.Sci.2019,6,1901041)
Disclosure of Invention
Aiming at the problem that cellulose derivative hydrogel in the prior art is easy to degrade, the lamellar silicon dioxide is added into the cellulose derivative hydrogel to improve the stability of the gel, and the problem that the viscosity of the gel is greatly increased after the lamellar silicon dioxide is added is solved by using polyethylene glycol, so that the injectable stable cellulose composite hydrogel is obtained.
The specific technical scheme of the invention is as follows:
a modified cellulose composite hydrogel comprises modified water-soluble cellulose and/or salts thereof, layered silicon dioxide, polyethylene glycol, inorganic salts and water.
Preferably, the modified water-soluble cellulose is polyanionic cellulose, and more preferably etherified cellulose (cellulose ether), including single ethers and mixed ethers. The single ethers include alkyl ethers (e.g., ethyl cellulose, propyl cellulose, benzyl cellulose, phenyl cellulose, cyanoethyl cellulose, etc.), hydroxyalkyl ethers (e.g., hydroxymethyl cellulose, hydroxyethyl cellulose (HEC), hydroxypropyl cellulose (HPC), etc.), carboxyalkyl ethers (e.g., carboxymethyl cellulose (CMC), carboxyethyl cellulose, etc.), mixed ethers refer to ethers having two or more groups attached to the molecular structure, such as benzyl cyanoethyl cellulose, carboxymethyl hydroxyethyl cellulose, carboxymethyl hydroxypropyl cellulose, hydroxypropyl methyl cellulose (HPMC), 2-hydroxy-3-butoxypropyl hydroxyethyl cellulose (HBPEC), etc. the etherified cellulose of the present invention may be selected from one or more of single ether and mixed ether celluloses.
The molecular weight of the modified water-soluble cellulose is 2000-2000000Da, and the substitution degree is 0.6-0.9. The molecular weight is preferably 90000-700000Da and the degree of substitution is preferably 0.7-0.9.
The molecular weight of the polyethylene glycol is 300-4000000 Da. Preferably 4000-10000 Da.
The layered silica material of the present invention is natural or synthetic, and in one specific example of the present invention, the layered silica is commercially available from Laponite XLG, BYK, germany.
The inorganic salt of the present invention is an alkali metal salt and/or an alkaline earth metal salt. The inorganic salt as electrolyte competes for water molecules with cellulose molecules in aqueous solution to achieve the effect of thickening. Preferably, the inorganic salt is a calcium salt and/or a sodium salt. One specific example is calcium chloride and sodium chloride.
Preferably, the mass ratio of the modified water-soluble cellulose to the layered silicon dioxide to the polyethylene glycol in the composite hydrogel is 0.05-5: 0.05-5: 0.05-10. Preferably 0.5 to 3: 0.5-3: 0.5-5.
Preferably, the mass percentages of the modified water-soluble cellulose, the layered silicon dioxide and the polyethylene glycol in the composite hydrogel are respectively 0.05-5%, 0.05-5% and 0.05-10%. Preferably 0.5-3%, 0.5-3% and 0.5-5%, more preferably, the composite hydrogel comprises carboxymethyl cellulose/sodium carboxymethyl cellulose, layered silicon dioxide, polyethylene glycol, calcium chloride, sodium chloride and water, wherein the molecular weight of the carboxymethyl cellulose is 90000-700000Da, the substitution degree is 0.7-0.9, the molecular weight of the polyethylene glycol is 4000-10000Da, and the mass ratio of the carboxymethyl cellulose to the layered silicon dioxide to the polyethylene glycol is 0.5-3: 0.5-3: 0.5-5.
According to a specific scheme, the composite hydrogel comprises carboxymethylcellulose/sodium carboxymethylcellulose, layered silicon dioxide, polyethylene glycol, calcium chloride, sodium chloride and water, wherein the molecular weight of the carboxymethylcellulose/sodium carboxymethylcellulose is 70000Da0, the substitution degree is 0.9, the molecular weight of the polyethylene glycol is 6000Da, and the mass percentage content of the carboxymethylcellulose/sodium carboxymethylcellulose, the layered silicon dioxide and the polyethylene glycol is 1.5%, 1.5% and 1.5%.
The invention also aims to provide application of the composite hydrogel in preparation of tissue fillers, tissue anti-adhesion agents, tissue engineering scaffolds, sealants or embolization agents.
The invention also provides a preparation method of the composite hydrogel, which comprises the steps of adding the modified water-soluble cellulose into water, uniformly stirring, continuously adding the layered silicon dioxide, uniformly stirring, further adding the mixed powder of the inorganic salt and the polyethylene glycol, and uniformly stirring to obtain the composite hydrogel.
The invention has the advantages that:
in the process of improving the stability of the cellulose hydrogel by using the lamellar silicon dioxide, the invention finds that although the lamellar silicon dioxide can improve the stability of the cellulose hydrogel, the viscosity of the system is greatly increased, which brings great problems to injection or intervention of the cellulose hydrogel through a thin catheter. In the process of solving the problems, the research of the invention unexpectedly discovers that the problem of high system viscosity can be obviously improved after polyethylene glycol is added into the system, and the stability of the cellulose hydrogel is ensured. Compared with a chemical crosslinking method, the technical scheme of the invention has the advantages of no introduction of a crosslinking agent and simple use, and has wide application prospect.
Detailed Description
The invention is described in further detail below with reference to specific examples and data, it being understood that these examples are intended to illustrate the invention and are not intended to limit the scope of the invention in any way.
Terms used in the present invention generally have meanings commonly understood by those of ordinary skill in the art, unless otherwise specified. In the following examples, various procedures and methods not described in detail are conventional methods well known in the art.
Example 1 preparation of CMC composite hydrogel
The effect of adding lamellar silicon dioxide and polyethylene glycol on the hydrogel viscosity was examined using CMC having a molecular weight of 70 ten thousand and a substitution rate of 0.9 as an example.
CMC hydrogel No. 1 sample: adding 0.5g of CMC with the molecular weight of 70 ten thousand Da and the substitution rate of 0.9 into 100mL of deionized water, and mechanically stirring uniformly to obtain a CMC hydrogel No. 1 sample.
CMC hydrogel No. 2 sample: adding 0.5g of CMC with the molecular weight of 70 ten thousand Da and the substitution rate of 0.9 into 100mL of deionized water, mechanically stirring uniformly, continuously adding 0.5g of layered silicon dioxide Laponite, and stirring uniformly to obtain a CMC hydrogel No. 2 sample.
CMC hydrogel No. 3 sample: 0.5g of CMC with the molecular weight of 70 ten thousand Da and the substitution rate of 0.9 is added into 100mL of deionized water and is mechanically stirred uniformly. 0.5g of Laponite was added and stirred well. Further adding 0.235g of CaCl2·2H2And O, 0.215g of NaCl and 1g of polyethylene glycol with the molecular weight of 6000Da are mixed and stirred uniformly to obtain a CMC hydrogel No. 3 sample.
CMC hydrogel No. 4 sample: adding 1.5g of CMC with the molecular weight of 70 ten thousand Da and the substitution rate of 0.9 into 100mL of deionized water, and mechanically stirring uniformly to obtain a CMC hydrogel No. 4 sample.
CMC hydrogel No. 5 sample: adding 1.5g of CMC with the molecular weight of 70 ten thousand Da and the substitution rate of 0.9 into 100mL of deionized water, mechanically stirring uniformly, continuously adding 0.5g of layered silicon dioxide Laponite, and stirring uniformly to obtain a CMC hydrogel No. 5 sample.
CMC hydrogel No. 6 sample: 1.5g of CMC with the molecular weight of 70 ten thousand Da and the substitution rate of 0.9 is added into 100mL of deionized water and is mechanically stirred uniformly. 0.5g of Laponite was added and stirred well. Further adding 0.235g of CaCl2·2H2O, 0.215g of NaCl and 0.25g of polyethylene glycol with the molecular weight of 6000Da are mixed and stirred uniformly to obtain a CMC hydrogel No. 6 sample.
CMC hydrogel sample No. 7: adding 5g of CMC with the molecular weight of 70 ten thousand Da and the substitution rate of 0.9 into 100mL of deionized water, and mechanically stirring uniformly to obtain a CMC hydrogel No. 7 sample.
CMC hydrogel No. 8 sample: adding 5g of CMC with the molecular weight of 70 ten thousand Da and the substitution rate of 0.9 into 100mL of deionized water, mechanically stirring uniformly, continuously adding 0.25g of layered silicon dioxide Laponite, and stirring uniformly to obtain a CMC hydrogel No. 8 sample.
CMC hydrogel No. 9 sample: 1.5g of CMC with the molecular weight of 70 ten thousand Da and the substitution rate of 0.9 is added into 100mL of deionized water and is mechanically stirred uniformly. 0.25g of Laponite was added and stirred well. Further adding 0.235g of CaCl2·2H2And O, 0.215g of NaCl and 5g of polyethylene glycol with the molecular weight of 6000Da are mixed and stirred uniformly to obtain a CMC hydrogel No. 9 sample.
And (3) viscosity measurement: the hydrogel sample obtained was subjected to viscosity measurement using an SNB rotary viscometer.
As shown in table 1, when the CMC was 0.5%, 1.5%, or 5% by mass, the viscosity of the CMC hydrogel system was greatly increased by adding the layered silica Laponite, and the viscosity of the system was significantly reduced by further adding PEG.
In particular, when the mass percent of CMC is 1.5%, by comparing the viscosities of samples hydrogel nos. 4-6, it was found that the viscosity of the CMC hydrogel system increased greatly by adding lamellar silica Laponite (hydrogel No. 5), increased by 37.97 times, and formed a viscous system with poor fluidity, while further adding PEG significantly reduced the system viscosity (hydrogel No. 6).
TABLE 1 Effect of layered silica and polyethylene glycol on cellulose hydrogel viscosity
Figure BDA0003372554420000041
Figure BDA0003372554420000051
Example 2
Taking CMC with molecular weight of 70 ten thousand Da and substitution rate of 0.9 as an example, the influence of adding polyethylene glycol with different molecular weight on the hydrogel viscosity is examined.
CMC hydrogel No. 10 sample: 1.5g of CMC with the molecular weight of 70 ten thousand Da and the substitution rate of 0.9 is added into 100mL of deionized water and is mechanically stirred uniformly. 1.5g of layered silica Laponite was added thereto and stirred well. Further adding 0.235g of CaCl2·2H2O, 0.215g of NaCl and 0.25g of polyethylene glycol with the molecular weight of 600Da are mixed and stirred uniformly to obtain a CMC hydrogel No. 10 sample.
CMC hydrogel No. 11 sample: 1.5g of CMC with the molecular weight of 70 ten thousand Da and the substitution rate of 0.9 is added into 100mL of deionized water and is mechanically stirred uniformly. 1.5g of layered silica Laponite was added thereto and stirred well. Further adding 0.235g of CaCl2 & 2H2O, 0.215g of NaCl and 0.25g of polyethylene glycol mixed powder with the molecular weight of 4000000Da, and uniformly stirring to obtain a CMC hydrogel No. 11 sample.
TABLE 2 Effect of different molecular weight polyethylene glycols on the viscosity of cellulose hydrogels
Figure BDA0003372554420000052
The results are shown in Table 2 and indicate that polyethylene glycol having a molecular weight in the range of 600-4000000 can significantly reduce the viscosity of cellulose gel to which layered silica is added.
EXAMPLE 3 polyethylene glycol Capacity to control the viscosity of cellulose hydrogels of different molecular weights
CMC hydrogel No. 12 sample: adding 1.5g of CMC with the molecular weight of 9 ten thousand Da and the substitution rate of 0.7 into 100mL of deionized water, and mechanically stirring uniformly to obtain a CMC hydrogel No. 12 sample.
CMC hydrogel No. 13 sample: adding 1.5g of CMC with the molecular weight of 9 ten thousand Da and the substitution rate of 0.7 into 100mL of deionized water, mechanically stirring uniformly, continuously adding 1.5g of layered silicon dioxide Laponite, and stirring uniformly to obtain a CMC hydrogel No. 13 sample.
CMC hydrogel No. 14 sample: 1.5g of CMC with the molecular weight of 9 ten thousand Da and the substitution rate of 0.7 is added into 100mL of deionized water and is mechanically stirred uniformly. 1.5g of layered silica Laponite was added thereto and stirred well. Further adding 0.235g of CaCl2·2H2O, 0.215g of NaCl and 1.5g of polyethylene glycol with the molecular weight of 6000Da are mixed and stirred uniformly to obtain a CMC hydrogel No. 14 sample.
As shown in Table 3, it is understood from the results of tables 1 and 2 that CMC having a molecular weight in the range of 9 to 70 ten thousand Da can form a composite gel having a desired viscosity with lamellar silica and polyethylene glycol.
TABLE 3 viscosity of 1.5% by weight CMC hydrogel samples
Figure BDA0003372554420000061
Example 4 stability of cellulose-polyethylene glycol-layered silica composite hydrogel according to the present invention, 1g of hydrogel sample was weighed and placed in a centrifuge tube, 10mL of phosphate buffered saline solution with pH of 7.4 was added, and stability test was performed in a constant temperature water bath shaker controlled at 37 ℃. And taking out the sample at regular intervals to observe the state, and determining the degradation endpoint when the obvious gel cannot be taken out. The stability test results of hydrogels 1-9 are shown in table 4, and compared with pure CMC hydrogel, the stability of hydrogel can be increased by adding lamellar silicon dioxide, and the stability is not affected by adding polyethylene glycol. For example, the hydrogel No. 1 is 0.5% CMC, the degradation period is 2 hours, the hydrogel No. 2 added with 0.5% lamellar silica has the degradation period prolonged to 20 hours, the hydrogel No. 3 further added with 1% polyethylene glycol and the hydrogel No. 9 added with 5% polyethylene glycol have the degradation period kept unchanged, and the degradation period of the hydrogel No. 6 is even obviously prolonged, which shows that the cellulose-polyethylene glycol-lamellar silica composite hydrogel disclosed by the invention has ideal viscosity and good stability.
TABLE 4 stability of CMC hydrogel samples
Figure BDA0003372554420000062
Figure BDA0003372554420000071

Claims (10)

1. A modified cellulose composite hydrogel is characterized by comprising modified water-soluble cellulose and/or salt thereof, layered silicon dioxide, polyethylene glycol, inorganic salt and water.
2. The composite hydrogel according to claim 1, wherein the modified water-soluble cellulose is a polyanionic cellulose.
3. The composite hydrogel according to claim 2, wherein the polyanionic cellulose is cellulose ether selected from one or more of methyl cellulose, hydroxyethyl methyl cellulose, carboxymethyl cellulose, ethyl hydroxyethyl cellulose, hydroxyethyl carboxymethyl cellulose, hydroxypropyl carboxymethyl cellulose, benzyl cellulose, hydroxyethyl cellulose, hydroxypropyl methyl cellulose, hydroxybutyl cellulose, cyanoethyl cellulose, benzyl cyanoethyl cellulose, carboxymethyl hydroxyethyl cellulose, and phenyl cellulose.
4. The composite hydrogel according to claim 1, wherein the modified water-soluble cellulose has a molecular weight of 2000-2000000Da and a degree of substitution of 0.6-0.9.
5. The composite hydrogel according to claim 1, wherein the molecular weight of the polyethylene glycol is 300-.
6. The composite hydrogel according to claim 1, wherein the inorganic salt is an alkali metal salt and/or an alkaline earth metal salt.
7. The composite hydrogel according to claim 1, wherein the mass ratio of the modified water-soluble cellulose to the layered silica to the polyethylene glycol is 0.05-5: 0.05-5: 0.05-10.
8. The composite hydrogel as claimed in claim 7, which comprises carboxymethylcellulose, layered silica, polyethylene glycol, calcium chloride, sodium chloride and water, wherein the molecular weight of carboxymethylcellulose is 90000-700000Da, the degree of substitution is 0.7-0.9, the molecular weight of polyethylene glycol is 4000-10000Da, and the mass ratio of carboxymethylcellulose, layered silica and polyethylene glycol is 0.5-3: 0.5-3: 0.5-5.
9. Use of the composite hydrogel according to any one of claims 1 to 8 for the preparation of a tissue filler, a tissue anti-adhesion agent, a tissue engineering scaffold, a sealant or an embolic agent.
10. The method for preparing a composite hydrogel according to any one of claims 1 to 8, wherein the modified water-soluble cellulose is added to water and stirred uniformly, the layered silica is further added and stirred uniformly, and the mixed powder of the inorganic salt and the polyethylene glycol is further added and stirred uniformly to obtain the composite hydrogel.
CN202111405230.2A 2021-11-24 2021-11-24 Cellulose-polyethylene glycol-layered silicon dioxide composite hydrogel and application thereof Active CN114133593B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111405230.2A CN114133593B (en) 2021-11-24 2021-11-24 Cellulose-polyethylene glycol-layered silicon dioxide composite hydrogel and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111405230.2A CN114133593B (en) 2021-11-24 2021-11-24 Cellulose-polyethylene glycol-layered silicon dioxide composite hydrogel and application thereof

Publications (2)

Publication Number Publication Date
CN114133593A true CN114133593A (en) 2022-03-04
CN114133593B CN114133593B (en) 2024-03-08

Family

ID=80392194

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111405230.2A Active CN114133593B (en) 2021-11-24 2021-11-24 Cellulose-polyethylene glycol-layered silicon dioxide composite hydrogel and application thereof

Country Status (1)

Country Link
CN (1) CN114133593B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538728A (en) * 1989-10-19 1996-07-23 Shiseido Company, Ltd. Hydrophilic polymer-silicate mineral complex material and use thereof
JPH09187493A (en) * 1996-01-10 1997-07-22 S T Chem Co Ltd Gel-like deodorizer
CN107973920A (en) * 2017-11-15 2018-05-01 深圳大学 A kind of cellulose/two-dimensional layer Material cladding hydrogel and preparation method thereof
CN110087633A (en) * 2016-12-15 2019-08-02 芬欧汇川集团 The method of the dry hydrogel comprising nanometer fibril cellulose and the hydrogel of the drying comprising nanometer fibril cellulose

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538728A (en) * 1989-10-19 1996-07-23 Shiseido Company, Ltd. Hydrophilic polymer-silicate mineral complex material and use thereof
JPH09187493A (en) * 1996-01-10 1997-07-22 S T Chem Co Ltd Gel-like deodorizer
CN110087633A (en) * 2016-12-15 2019-08-02 芬欧汇川集团 The method of the dry hydrogel comprising nanometer fibril cellulose and the hydrogel of the drying comprising nanometer fibril cellulose
CN107973920A (en) * 2017-11-15 2018-05-01 深圳大学 A kind of cellulose/two-dimensional layer Material cladding hydrogel and preparation method thereof

Also Published As

Publication number Publication date
CN114133593B (en) 2024-03-08

Similar Documents

Publication Publication Date Title
EP2783702B1 (en) Water insoluble gel composition and method for preparing same
CN101925348B (en) Biodegradable single-phase cohesive hydrogel
EP1753787B1 (en) Method of covalently linking hyaluronan and chitosan
KR101868183B1 (en) Process of preparing a cross linked gel
US20050281880A1 (en) Methods for making injectable polymer hydrogels
KR20170090965A (en) Combination of crosslinked hyaluronic acids and a process for preparation thereof
JP2004323453A (en) Decomposable gel and method for producing the same
ITPD20000207A1 (en) NEW CROSS-LINKATED DERIVATIVES OF HYALURONIC ACID.
KR20180122758A (en) Method of preparing a composition based on hyaluronic acid
CN104327311B (en) A kind of hyaluronic acid composite crosslinking hydrogel and preparation method thereof
CN112516075B (en) Prednisone-loaded hyaluronic acid-chitosan temperature-sensitive hydrogel and preparation method thereof
EP2844310B1 (en) Shape-memory cross-linked polysaccharides
CN104231285A (en) Hyaluronic acid derivative gel and preparing method thereof
CN114133593B (en) Cellulose-polyethylene glycol-layered silicon dioxide composite hydrogel and application thereof
CN106999626A (en) Biocompatible composition and preparation method
CN107955194A (en) The preparation method of high quality cross-linking sodium hyaluronate gel
CN113769159A (en) Anhydrous calcium phosphate bone cement and preparation method thereof
CN114026157A (en) Method for crosslinking polymers
JPWO2018079812A1 (en) Gel composition and method for producing the same
CN109810264B (en) Low-modified high-viscosity hyaluronic acid gel and preparation method and application thereof
CN107880288A (en) A kind of preparation method of hyaluronic acid sodium gel
CN115671405B (en) Joint cavity injection gel and preparation method thereof
CN117298355B (en) Coated hyaluronic acid gel composition and preparation method and application thereof
CN114395144A (en) Hyaluronic acid-polyethylene glycol-layered silicon dioxide composite hydrogel and application thereof
CN117720748A (en) Preparation method of crosslinked hydrogel

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant